Interpace Biosciences®, Inc. Annual report pursuant to Section 13 and 15(d)

Recent Accounting Standards	12 Months Ended
Recent Accounting Standards	Dec. 31, 2013
Recent Accounting Standards [Abstract]
Significant Accounting Policies [Text Block]	Recent Accounting Standards Accounting Standards Updates In February 2013, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2013-02, Comprehensive Income (Topic 220), "Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income," effective for annual and interim reporting periods beginning after December 15, 2012. The new accounting rules require all U.S. public companies to report the effect of items reclassified out of accumulated other comprehensive income on the respective line items of net income, net of tax, either on the face of the financial statements where net income is presented or in a tabular format in the notes to the financial statements. The Company adopted ASU No. 2013-02 effective January 1, 2013. The new accounting rules expand the disclosure of other comprehensive income and had no impact on the Company's results of operations and financial condition.

The entire disclosure for all significant accounting policies of the reporting entity.